Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +3.21% | -0.82% |
05-02 | Dabur India beats Q4 profit view on steady domestic demand, lower costs | RE |
05-02 | Deutsche Bank likes TP ICAP but says sell CMC | AN |
Strengths
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.82% | 132B | - | ||
+12.23% | 388B | C- | ||
+16.52% | 76.2B | A+ | ||
-16.82% | 62.43B | A- | ||
-9.10% | 47.67B | B+ | ||
-10.82% | 36.76B | - | ||
+5.49% | 34.51B | B- | ||
+9.88% | 17.86B | A- | ||
+10.61% | 15.35B | B | ||
-4.57% | 11.3B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- ULVR Stock
- 0NXN Stock
- Ratings Unilever N.V.